171 related articles for article (PubMed ID: 11971909)
21. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
Fan B; Turko IV; Gettins PG
Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
[TBL] [Abstract][Full Text] [Related]
22. The role of Arg46 and Arg47 of antithrombin in heparin binding.
Arocas V; Bock SC; Olson ST; Björk I
Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
[TBL] [Abstract][Full Text] [Related]
23. Antithrombin III phenylalanines 122 and 121 contribute to its high affinity for heparin and its conformational activation.
Jairajpuri MA; Lu A; Desai U; Olson ST; Bjork I; Bock SC
J Biol Chem; 2003 May; 278(18):15941-50. PubMed ID: 12556442
[TBL] [Abstract][Full Text] [Related]
24. Activation of antithrombin as a factor IXa and Xa inhibitor involves mitigation of repression rather than positive enhancement.
Gettins PG; Olson ST
FEBS Lett; 2009 Nov; 583(21):3397-400. PubMed ID: 19818773
[TBL] [Abstract][Full Text] [Related]
25. Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.
Ersdal-Badju E; Lu A; Peng X; Picard V; Zendehrouh P; Turk B; Björk I; Olson ST; Bock SC
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):323-30. PubMed ID: 7646463
[TBL] [Abstract][Full Text] [Related]
26. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
Turk B; Brieditis I; Bock SC; Olson ST; Björk I
Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
[TBL] [Abstract][Full Text] [Related]
27. The conformational activation of antithrombin. A 2.85-A structure of a fluorescein derivative reveals an electrostatic link between the hinge and heparin binding regions.
Huntington JA; McCoy A; Belzar KJ; Pei XY; Gettins PG; Carrell RW
J Biol Chem; 2000 May; 275(20):15377-83. PubMed ID: 10809774
[TBL] [Abstract][Full Text] [Related]
28. Role of arginine 129 in heparin binding and activation of antithrombin.
Desai U; Swanson R; Bock SC; Bjork I; Olson ST
J Biol Chem; 2000 Jun; 275(25):18976-84. PubMed ID: 10764763
[TBL] [Abstract][Full Text] [Related]
29. The allosteric mechanism of activation of antithrombin as an inhibitor of factor IXa and factor Xa: heparin-independent full activation through mutations adjacent to helix D.
Dementiev A; Swanson R; Roth R; Isetti G; Izaguirre G; Olson ST; Gettins PGW
J Biol Chem; 2013 Nov; 288(47):33611-33619. PubMed ID: 24068708
[TBL] [Abstract][Full Text] [Related]
30. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
31. Heparin-dependent modification of the reactive center arginine of antithrombin and consequent increase in heparin binding affinity.
Pike RN; Potempa J; Skinner R; Fitton HL; McGraw WT; Travis J; Owen M; Jin L; Carrell RW
J Biol Chem; 1997 Aug; 272(32):19652-5. PubMed ID: 9242619
[TBL] [Abstract][Full Text] [Related]
32. Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the heparin-antithrombin complex.
Rezaie AR
Blood; 2001 Apr; 97(8):2308-13. PubMed ID: 11290592
[TBL] [Abstract][Full Text] [Related]
33. Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically promote the inhibition of factor Xa and factor IXa.
Izaguirre G; Rezaie AR; Olson ST
J Biol Chem; 2009 Jan; 284(3):1550-8. PubMed ID: 19010776
[TBL] [Abstract][Full Text] [Related]
34. Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamine.
Gandrille S; Aiach M; Lane DA; Vidaud D; Molho-Sabatier P; Caso R; de Moerloose P; Fiessinger JN; Clauser E
J Biol Chem; 1990 Nov; 265(31):18997-9001. PubMed ID: 2229057
[TBL] [Abstract][Full Text] [Related]
35. Heparin binding site, conformational change, and activation of antithrombin.
Evans DL; Marshall CJ; Christey PB; Carrell RW
Biochemistry; 1992 Dec; 31(50):12629-42. PubMed ID: 1366018
[TBL] [Abstract][Full Text] [Related]
36. Importance of the P2 glycine of antithrombin in target proteinase specificity, heparin activation, and the efficiency of proteinase trapping as revealed by a P2 Gly --> Pro mutation.
Chuang YJ; Gettins PG; Olson ST
J Biol Chem; 1999 Oct; 274(40):28142-9. PubMed ID: 10497166
[TBL] [Abstract][Full Text] [Related]
37. Allosteric activation of antithrombin critically depends upon hinge region extension.
Langdown J; Johnson DJ; Baglin TP; Huntington JA
J Biol Chem; 2004 Nov; 279(45):47288-97. PubMed ID: 15326167
[TBL] [Abstract][Full Text] [Related]
38. Mutagenesis of recombinant protein C inhibitor reactive site residues alters target proteinase specificity.
Phillips JE; Cooper ST; Potter EE; Church FC
J Biol Chem; 1994 Jun; 269(24):16696-700. PubMed ID: 8206990
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
[TBL] [Abstract][Full Text] [Related]
40. Partial glycosylation of antithrombin III asparagine-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.
Picard V; Ersdal-Badju E; Bock SC
Biochemistry; 1995 Jul; 34(26):8433-40. PubMed ID: 7599134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
